Literature DB >> 12638376

Epidemiology of melanoma and nonmelanoma skin cancer.

Alan C Geller1, George D Annas.   

Abstract

OBJECTIVES: To describe the epidemiology of melanoma and nonmelanoma skin cancers. DATA SOURCES: Review and research articles, book chapters, and Surveillance, Epidemiology, and End Results (SEER) data.
CONCLUSIONS: In 2002, an estimated 1.3 million Americans were diagnosed with skin cancer. Of these, 53,000 individuals were diagnosed with melanoma, the most common fatal form of skin cancer, and more than 7,000 Americans died of melanoma. Nonmelanoma skin cancer has the highest incidence of all cancers and the rise in the rate of cutaneous melanoma exceeds all other preventable cancers. IMPLICATIONS FOR NURSING PRACTICE: Nurses can act as case-finders and as advocates and educators for prevention of overexposure to ultraviolet radiation. Nurses should ascertain possible inherited risk and monitor patients for additional primary skin cancers.

Entities:  

Mesh:

Year:  2003        PMID: 12638376     DOI: 10.1053/sonu.2003.50000

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  23 in total

Review 1.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

2.  Pomegranate fruit extract inhibits UVB-induced inflammation and proliferation by modulating NF-κB and MAPK signaling pathways in mouse skin.

Authors:  Naghma Khan; Deeba N Syed; Harish Chandra Pal; Hasan Mukhtar; Farrukh Afaq
Journal:  Photochem Photobiol       Date:  2012-01-13       Impact factor: 3.421

3.  Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation.

Authors:  Kausar M Ansari; Joyce E Rundhaug; Susan M Fischer
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

4.  P-cadherin counteracts myosin II-B function: implications in melanoma progression.

Authors:  Koen Jacobs; Mireille Van Gele; Ramses Forsyth; Lieve Brochez; Barbara Vanhoecke; Olivier De Wever; Marc Bracke
Journal:  Mol Cancer       Date:  2010-09-22       Impact factor: 27.401

5.  Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.

Authors:  Martin A Weinstock; Kachiu C Lee; Mary-Margaret Chren; Kimberly Marcolivio
Journal:  J Am Acad Dermatol       Date:  2009-04-26       Impact factor: 11.527

6.  Visualization of UV exposure of the human body based on data from a scanning UV-measuring system.

Authors:  P Hoeppe; A Oppenrieder; C Erianto; P Koepke; J Reuder; M Seefeldner; D Nowak
Journal:  Int J Biometeorol       Date:  2004-06-30       Impact factor: 3.787

Review 7.  Intralesional treatment of metastatic melanoma: a review of therapeutic options.

Authors:  Benjamin Weide; Dario Neri; Giuliano Elia
Journal:  Cancer Immunol Immunother       Date:  2017-01-11       Impact factor: 6.968

Review 8.  Nucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer Therapy.

Authors:  Elzbieta Pawlowska; Daniel Wysokinski; Janusz Blasiak
Journal:  Int J Mol Sci       Date:  2016-04-06       Impact factor: 5.923

9.  Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms.

Authors:  Jianbo Yang; Matthew A Price; Cheryl L Neudauer; Christopher Wilson; Soldano Ferrone; Hong Xia; Joji Iida; Melanie A Simpson; James B McCarthy
Journal:  J Cell Biol       Date:  2004-06-21       Impact factor: 10.539

10.  A Formulation Study of 5-Aminolevulinic Encapsulated in DPPC Liposomes in Melanoma Treatment.

Authors:  Ming-Wei Lin; Yaw-Bin Huang; Chun-Lin Chen; Pao-Chu Wu; Chien-Ying Chou; Ping-Ching Wu; Shih-Ya Hung
Journal:  Int J Med Sci       Date:  2016-06-18       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.